Invention Grant
- Patent Title: Method of diagnosing neoplasms
-
Application No.: US14824522Application Date: 2015-08-12
-
Publication No.: US10344334B2Publication Date: 2019-07-09
- Inventor: Lawrence Charles LaPointe , Robert Dunne , Graeme P. Young , Peter Molloy , Susanne Pedersen , Glenn Southwell Brown , Lloyd Douglas Graham
- Applicant: CLINICAL GENOMICS PTY. LTD. , COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
- Applicant Address: AU North Ryde AU Campbell
- Assignee: CLINICAL GENOMICS PTY. LTD.,COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
- Current Assignee: CLINICAL GENOMICS PTY. LTD.,COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
- Current Assignee Address: AU North Ryde AU Campbell
- Agency: Scully Scott Murphy & Presser
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886 ; G01N33/574

Abstract:
Disclosed are nucleic acid, RNA, and protein expression profiles which are indicative of the onset, predisposition to the onset and/or progression of a large intestine neoplasm. More particularly disclosed are nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a colorectal neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenomas and adenocarcinomas. Further disclosed are methods of screening a subject for the onset, predisposition to the onset and/or progression of a large intestine neoplasm by screening for modulation in the expression profile of the disclosed nucleic acid molecule markers.
Public/Granted literature
- US20160130657A1 METHOD OF DIAGNOSING NEOPLASMS Public/Granted day:2016-05-12
Information query